AJB Investment Fund II, LP (Bradley Adam James, Bradley Melinda Hodges) purchased $13K of JCTC (indirect holdings)

AJB Investment Fund II, LP purchased 4,638 indirectly-held shares of JEWETT CAMERON TRADING CO LTD (JCTC) at $2.90 across 3 trades over 2026-10-13 to 2026-10-15. Filed jointly with AJB Capital, LLC (10% owner), Bradley Adam James (10% owner) and Bradley Melinda Hodges (10% owner).

Original reporting
SEC EDGAR · AJB Investment Fund II, LP, AJB Capital, LLC, Bradley Adam James, Bradley Melinda Hodges
Published Oct 15, 2026, 10:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 10:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$JCTC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

No new company fundamentals, corporate actions, or regulatory developments are disclosed. The filing provides transaction size, price, and post-transaction share count, which is typically low-signal for trading without corroborating operational news.

02

Market read

Traders may note insider buying, but the disclosure alone is unlikely to drive price action absent additional company-specific catalysts.

03

What to watch

The transaction is indirect and the issuer is a foreign-listed company with no US ticker provided here, limiting tradability and signal strength versus company-specific news.

Relevance 3/10Novelty 2/10Timing: filed 2026-10-15, covering purchases dated 2026-10-13 to 2026-10-15

Background

The article is an SEC Form 4 insider transaction disclosure, reporting an open-market purchase by AJB Investment Fund II, LP (10% owner) with indirect holdings in JEWETT CAMERON TRADING CO LTD (JCTC).

Market effects

None. This is a routine insider transaction with no disclosed business or sector catalyst.

None.

None.

Counterpoint

A non-10b5-1 plan is not indicated, but the filing still may reflect diversification or tax/estate planning rather than a bullish view on near-term fundamentals.

Key entities

  • AJB Investment Fund II, LP

    Reporter of the Form 4, disclosed as a 10% owner making an open-market purchase via indirect holdings.

  • JEWETT CAMERON TRADING CO LTD

    The company whose shares were purchased, disclosed as JCTC in the Form 4.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).